Grants
Grants listed represent those for which Johns Hopkins Infectious Diseases researchers are principal investigators.
Displaying 1 - 10 of 49 results
-
Clinical Validation & Usability Assessment of the statID Pro HBsAg Test for Point-of-Care (POC)
Date:
12/01/2025Topics:
Lead Investigators:
-
HCV Elimination in PWID in the United States: HERO in practice
Date:
11/01/2025Topics:
Lead Investigators:
-
Hepatitis B and HIV Care Consortium
Date:
09/17/2025Locations:
Topics:
Lead Investigators:
-
A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 Administered as a Single Ascending Dose and Multiple Ascending Doses in Participants with Chronic Hepatitis B Virus Infection
Date:
09/01/2025Topics:
Lead Investigators:
-
A Randomized, Double-Blind, Active-Controlled Multicenter Phase 2 Study Evaluating the Efficacy and Safety of ALG-000184Compared with Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg-Negative Adult Subjects with Chronic Hepatitis BVirus Infection (B-SUPREME)
Date:
07/01/2025Topics:
Lead Investigators:
-
A Global, Randomized, Open-label, Multicenter, Phase 2b/3 Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection(AZURE-1)
Date:
07/01/2025Topics:
Lead Investigators:
-
Phase 3, Randomized, Controlled, Open-label Study to Compare the Efficacy and Safety of Bemnifosbuvir-Ruzasvir Fixed dose Combination (BEM/RZR FDC) Versus Sofosbuvir-Velpatasvir Fixed-dose Combination (SOF/VEL FDC) in Subjects with Chronic Hepatitis C Virus (HCV) Infection
Date:
05/01/2025Topics:
Lead Investigators:
-
A Phase 2b Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Tobevibart+Elebsiran Combination Therapyin Participants with Chronic HDV Infection (ECLIPSE)
Date:
03/01/2025Topics:
Lead Investigators:
-
A Multicenter, Randomized, Double-Blind, Placebo controlled Study to Assess the Efficacy and Safety of Treatment with Bepirovirsen in Participants living with Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection on Antiretroviral Treatment
Date:
12/01/2024Topics:
Lead Investigators:
-
Dissecting Hepatitis B Vaccine Adjuvant Effects on Immune Responses and the HIV Reservoir in PLWH
Date:
07/25/2024Topics:
Lead Investigators: